Clinical Trial Update: A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update for CNTX-4975-05 assessing efficacy and safety in osteoarthritis knee pain has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• CNTX-4975-05

Snippet

Sponsor: Centrexion Therapeutics | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED | Results posted: 2022-07-21